[Biodynamics of 1,2 alpha-methyl-6-chloro-pregna-4,6-diene-17 alpha-acetoxy-3,20-dione (cyproterone acetate) after oral administration in man. On alkyl-substituted steroids. IX].
D000085:Acetates / Q000378:metabolism; D000284:Administration, Oral; D001798:Blood Proteins / Q000378:metabolism; D002845:Chromatography; D003534:Cyproterone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D004586:Electrophoresis; D005243:Feces / Q000032:analysis; D005966:Glucuronidase; D006207:Half-Life; D006801:Humans; D006868:Hydrolysis; D007408:Intestinal Absorption; D008297:Male; D010084:Oxidation-Reduction; D011956:Receptors, Cell Surface; D013431:Sulfates / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000085:Acetates; D001798:Blood Proteins; D011956:Receptors, Cell Surface; D013431:Sulfates; D014316:Tritium; D003534:Cyproterone; D005966:Glucuronidase
Biodynamik von 1,2 alpha-Methylen-6-chlor-pregna-4,6-dien-17 alpha-acetoxy-3,20-dion (Cyproteron-acetat) nach oraler Verabreichung beim Menschen. Uber Alkyl-substituierte Steroide, I.